Satoshi Sakamoto Selected Research

Steroids

4/2018

Successful Treatment of Rapidly Progressive Unclassifiable Idiopathic Interstitial Pneumonia with Anti-melanoma Differentiation-associated Gene-5 Antibody by Intensive Immunosuppressive Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Sakamoto Research Topics

Disease

10	Neoplasms (Cancer) 01/2020 - 07/2008
2	Fibrosis (Cirrhosis) 07/2020 - 12/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Idiopathic Pulmonary Fibrosis 07/2020
1	Multiple Myeloma 01/2020
1	Pulmonary Arterial Hypertension 01/2020
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Idiopathic Interstitial Pneumonias 04/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2018
1	Pneumoconiosis 12/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Carcinoma (Carcinomatosis) 04/2014
1	Heart Failure 05/2013
1	Bone Resorption 02/2010
1	Adenoviridae Infections (Adenovirus Infections) 02/2010
1	Virus Diseases (Viral Diseases) 02/2010
1	Osteoporosis 02/2010
1	Rheumatoid Arthritis 11/2009

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 08/2013
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	Periodic AcidIBA 07/2020
1	AsbestosIBA 07/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	pomalidomideIBA 01/2020
1	Carbon MonoxideIBA 01/2020
1	Thalidomide (Thalomid)FDA Link 01/2020
1	Biological ProductsIBA 03/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Keratins (Keratin)IBA 01/2019
1	ParaffinIBA 01/2019
1	Carcinoembryonic AntigenIBA 10/2018
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 10/2018
1	human ERBB2 proteinIBA 10/2018
1	SteroidsIBA 04/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2018
1	IndiumIBA 12/2017
1	CholesterolIBA 12/2017
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2016
1	MacrolidesIBA 01/2016
1	Gefitinib (Iressa)FDA Link 01/2016
1	Epidermal Growth Factor (EGF)IBA 08/2013
1	Ferrosoferric Oxide (Magnetite)FDA Link 08/2013
1	vesnarinoneIBA 05/2013
1	QuinolonesIBA 05/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Monomeric GTP-Binding ProteinsIBA 02/2010
1	Diphosphonates (Bisphosphonates)IBA 02/2010
1	Diphosphates (Pyrophosphates)IBA 02/2010
1	Antiviral Agents (Antivirals)IBA 02/2010
1	NitrogenIBA 02/2010
1	Pharmaceutical PreparationsIBA 11/2009
1	Methotrexate (Mexate)FDA LinkGeneric 07/2008
1	LigandsIBA 07/2008

Therapy/Procedure

3	Therapeutics 04/2018 - 03/2013
1	Drug Therapy (Chemotherapy) 01/2016